T1	Participants 333 459	551 participants enrolled in a prospective, randomized study of fluorescence cystoscopy for Ta or T1 urothelial bladder cancer
T2	Participants 483 531	280 patients in the white light cystoscopy group
T3	Participants 536 672	271 in the fluorescence cystoscopy group were followed with cystoscopy for 3, 6 and 9 months after initial resection or until recurrence
T4	Participants 769 852	information was obtained for 261 of the 280 patients (93%) in the white light group
T5	Participants 857 903	255 of the 271 (94%) in the fluorescence group
